|1.||Gleich, G J: 3 articles (10/2013 - 02/2001)|
|2.||Cosin-Sales, Juan: 2 articles (05/2008 - 04/2004)|
|3.||Holt, David W: 2 articles (05/2008 - 04/2004)|
|4.||Christiansen, Michael: 2 articles (05/2008 - 04/2004)|
|5.||Kaski, Juan Carlos: 2 articles (05/2008 - 04/2004)|
|6.||Schwantes, E A: 1 article (06/2014)|
|7.||Gern, J E: 1 article (06/2014)|
|8.||Manthei, D M: 1 article (06/2014)|
|9.||Mathur, S K: 1 article (06/2014)|
|10.||Evans, M D: 1 article (06/2014)|
|1.||Pulmonary Eosinophilia (Eosinophilic Pneumonia)
10/01/1998 - "The current study examined the effect of IL-12 on pulmonary eosinophilia, deposition of eosinophil major basic protein and airway hyperresponsiveness in mice inoculated i.v. with Brugia malayi microfilariae. "
01/01/1993 - "Cells from bronchoalveolar lavage fluid of four patients with chronic eosinophilic pneumonia and four patients with eosinophilic infiltrates associated with Sjögren's syndrome, drug hypersensitivity pneumonia, postradiotherapy fibrosis, and pulmonary disease associated with graft versus host disease were studied ultrastructurally and with immunogold labelled antibodies directed against eosinophil proteins: major basic protein, eosinophil cationic protein, and Charcot-Leyden crystal protein. "
|2.||Drug-Induced Liver Injury
04/01/2001 - "Immunohistochemical studies with antibodies against eosinophil cationic proteins (major basic protein, eosinophil-derived neurotoxin and eosinophil cationic protein), cytokines (interleukin 5 (IL-5), interleukin 3 (IL-3) and granulocyte-macrophage colony stimulating factor (GM-CSF)) and chemokines (eotaxin and RANTES (Regulated upon Activation Normal T cell Expressed and Secreted)) were performed to assess the in situ activation of the liver-infiltrating eosinophils of 14 patients with drug-induced liver disease and 19 controls. "
|3.||Asthma (Bronchial Asthma)
02/01/2001 - "Human eosinophil major basic protein (MBP) is strongly implicated as a mediator of disease, especially bronchial asthma. "
07/01/1997 - "In airways from three patients with fatal asthma, 196 of 637 eosinophils (30%) were associated with nerves, and release of eosinophil major basic protein was evident; conversely, in three control patients 1 of 11 (9%) eosinophils were in contact with nerves. "
06/01/2007 - "Eosinophils cluster along airway nerves in patients with asthma and release eosinophil major basic protein, an antagonist of inhibitory M2 muscarinic receptors on nerves. "
09/01/2006 - "To investigate the expression of eosinophil major basic protein (MBP) mRNA in bronchial asthma and explore its significance. "
09/01/2006 - "[Expression of eosinophil major basic protein mRNA in bronchial asthma]."
11/01/1994 - "Measurements of eosinophilia (peripheral and bone marrow counts), levels of serum eosinophil major basic protein, doses of glucocorticoid and cytotoxic medications, and transfusion requirements. "
03/01/1991 - "Tissue eosinophilia was prominent in all specimens; striking extracellular deposition of eosinophil major basic protein was noted in three patients, and focal deposition was present in the fourth patient. "
08/01/1997 - "Elevated serum levels of eosinophil major basic protein in patients with myeloproliferative disorders without eosinophilia."
03/01/1991 - "Orbital specimens obtained at autopsy from patients without orbital disease were studied as control specimens; no tissue eosinophilia or deposition of eosinophil major basic protein was observed. "
01/01/1991 - "Chronic airway eosinophilia, intratracheal instillation of eosinophil major basic protein, repeated antigen inhalation, and airway epithelial desquamation induced, or were associated with, an increase in airway responsiveness. "
01/01/1997 - "Eosinophil major basic protein in autologous serum and saline skin tests in chronic idiopathic urticaria."
07/01/1989 - "Thus evolution of the solar urticaria wheal is accompanied by infiltration of eosinophils and neutrophils and by tissue deposition of the eosinophil major basic protein, suggesting eosinophil degranulation."
04/01/1992 - "Using delayed pressure urticaria as a model, evidence has emerged of the role of eosinophil major basic protein (MBP) and of interleukin-6 (IL-6) as important molecular mediators, possibly explaining the poor response to H1 antihistamines. "
|2.||Eosinophil Cationic Protein
|4.||Proteins (Proteins, Gene)
|7.||Interleukin-12 (IL 12)
|8.||Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
|9.||Interleukin-5 (Interleukin 5)
|10.||Interleukin-3 (Interleukin 3)